
AI at the crossroads: Global developments shaping life sciences
0:00
27:24
In this episode of Talking the Cure, Hogan Lovells partners Phil Katz, Melissa Bianchi, and Jodi Scott explore how artificial intelligence is transforming the pharmaceutical, biotech, and medical device industries. From AI-driven clinical trials and diagnostic tools to regulatory challenges and global compliance complexities, the discussion dives deep into both the promise and the pitfalls of integrating AI in health care. Tune in to hear how industry leaders are navigating this fast-evolving space – and what companies need to know to stay ahead.
Flere episoder fra "Talking the Cure by Hogan Lovells Cadwalader"



Gå ikke glip af nogen episoder af “Talking the Cure by Hogan Lovells Cadwalader” - abonnér på podcasten med gratisapp GetPodcast.








